BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Emanuele Pontali, Vito Fiore, Anna Maria Ialungo, Roberto Ranieri, Oscar Mollaretti, Giorgio Barbarini, Daniele Marri, Tullio Prestileo, Serena Dell’Isola, Elena Rastrelli, Guido Leo, Giulio Starnini, Sergio Babudieri, Giordano Madeddu. Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in ItalyInternational Journal of Drug Policy 2018; 59: 50 doi: 10.1016/j.drugpo.2018.06.017
2
A. Marco, M. Roget, M. Cervantes, M. Forné, R. Planella, M. Miquel, J. Ortiz, M. Navarro, C. Gallego, M. Vergara. Comparison of effectiveness and discontinuation of interferon-free therapy for hepatitis C in prison inmates and noninmatesJournal of Viral Hepatitis 2018; 25(11): 1280 doi: 10.1111/jvh.12940
3
Nadine Kronfli, Blake Linthwaite, Fiona Kouyoumdjian, Marina B. Klein, Bertrand Lebouché, Giada Sebastiani, Joseph Cox. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic reviewInternational Journal of Drug Policy 2018; 57: 95 doi: 10.1016/j.drugpo.2018.04.003
4
H. Stöver, F. Meroueh, A. Marco, K. Keppler, P. Saiz de la Hoya, R. Littlewood, N. Wright, F. Nava, F. Alam, S. Walcher, L. Somaini. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in EuropeBMC Public Health 2019; 19(1) doi: 10.1186/s12889-018-6357-x
5
Masoud Behzadifar, Meysam Behzadifar, Nicola Luigi Bragazzi. A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in IranBMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-8175-1
6
M. Maticic, Z. Pirnat, A. Leicht, R. Zimmermann, T. Windelinck, M. Jauffret-Roustide, E. Duffell, T. Tammi, E. Schatz. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countriesHarm Reduction Journal 2020; 17(1) doi: 10.1186/s12954-020-00439-3
7
Zameer Mohamed, Deyaa Al-Kurdi, Margaret Nelson, Yusuke Shimakawa, Nowlan Selvapatt, Janine Lacey, Mark R Thursz, Maud Lemoine, Ashley S Brown. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in EnglandInternational Journal of Drug Policy 2020; 75: 102608 doi: 10.1016/j.drugpo.2019.102608
8
Chun-Han Cheng, Ching-Chung Lin, Huan-Lin Chen, I-Tsung Lin, Chia-Hsien Wu, Yuan-Kai Lee, Ming-Jong Bair, Chen-Hua Liu. Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infectionPLOS ONE 2018; 13(2): e0191799 doi: 10.1371/journal.pone.0191799
9
Maike Neuhaus, Danette Langbecker, Liam J Caffery, Monica Taylor, Lisa Garner, Gayle Williams, Anthony C Smith, Graeme A Macdonald. Telementoring for hepatitis C treatment in correctional facilitiesJournal of Telemedicine and Telecare 2018; 24(10): 690 doi: 10.1177/1357633X18795361
10
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi. Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysisHarm Reduction Journal 2018; 15(1) doi: 10.1186/s12954-018-0231-0
11
Javier Crespo, Susana Llerena, Carmen Cobo, Joaquin Cabezas, Antonio Cuadrado. HCV Management in the Incarcerated Population: How Do We Deliver on This Important Front?Current Hepatology Reports 2019; 18(2): 259 doi: 10.1007/s11901-019-00472-2
12
Tânia Maria Pazin Marques Silva, Lirane Elize Defante Ferreto, Franciele Ani Caovilla Follador, Ana Paula Vieira, Roberto Shigueyasu Yamada, Léia Carolina Lucio, Joana Perotta Titon, Renata Himovski Torres, Greicy Cézar do Amaral, Harnoldo Colares Coelho. Characteristics associated with anti-HCV serological markers in prisoners in the state of Paraná, Brazil: a case-control studyThe Brazilian Journal of Infectious Diseases 2019; 23(3): 173 doi: 10.1016/j.bjid.2019.05.007
13
Frederick L Altice, Lyuba Azbel, Jack Stone, Ellen Brooks-Pollock, Pavlo Smyrnov, Sergii Dvoriak, Faye S Taxman, Nabila El-Bassel, Natasha K Martin, Robert Booth, Heino Stöver, Kate Dolan, Peter Vickerman. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central AsiaThe Lancet 2016; 388(10050): 1228 doi: 10.1016/S0140-6736(16)30856-X
14
Roberto Ranieri, Giulio Starnini, Sergio Carbonara, Emanuele Pontali, Guido Leo, Antonio Romano, Sandro Panese, Roberto Monarca, Tullio Prestileo, Giorgio Barbarini, Sergio Babudieri. Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panelInfection 2017; 45(2): 131 doi: 10.1007/s15010-016-0973-0
15
Sofia R Bartlett, Penny Fox, Harris Cabatingan, Anissa Jaros, Carla Gorton, Rhondda Lewis, Eugene Priscott, Gregory J Dore, Darren B Russell. Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment ProjectClinical Infectious Diseases 2018; 67(3): 460 doi: 10.1093/cid/ciy210
16
You-Wen Tan, Yan Tao, Long-Gen Liu, Yun Ye, Xin-Bei Zhou, Li Chen, Cong He. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period surveyWorld Journal of Gastroenterology 2018; 24(11): 1250-1258 doi: 10.3748/wjg.v24.i11.1250
17
Dalbir S. Sandhu, Randhir Jesudoss. Viral Hepatitis: Chronic Hepatitis C2019; : 109 doi: 10.1007/978-3-030-03757-4_6
18
Mario Masarone, Rosa Caruso, Andrea Aglitti, Carmine Izzo, Giuseppe De Matteis, Maria Rosaria Attianese, Antonio Maria Pagano, Marcello Persico. Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment programDigestive and Liver Disease 2020; 52(5): 541 doi: 10.1016/j.dld.2020.02.012
19
Nadine Kronfli, Roy Nitulescu, Joseph Cox, Erica EM Moodie, Alexander Wong, Curtis Cooper, John Gill, Sharon Walmsley, Valérie Martel-Laferrière, Mark W Hull, Marina B Klein. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in CanadaJournal of the International AIDS Society 2018; 21(11): e25197 doi: 10.1002/jia2.25197
20
Winston J. Warme. CORR Insight s ®: Is Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty?Clinical Orthopaedics & Related Research 2016; 474(12): 2670 doi: 10.1007/s11999-016-5043-5
21
Ghobad Moradi, Mohammad-Mehdi Gouya, Fatemeh Azimizan Zavareh, Amjad Mohamadi Bolbanabad, Sonia Darvishi, Mohammad Reza Aghasadeghi, Mahmood Nabavi, Ramin Alasvand, Mehrzad Tashakorian, Bijan Nouri, Khaled Rahmani, Leila Molaei. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015Tropical Medicine & International Health 2018; 23(6): 641 doi: 10.1111/tmi.13065
22
Sameera Mokkarala, Cole Johnson, Souvik Sarkar, Robert J. Rudas. Family Practitioner–Directed Hepatitis C Therapy With Direct-Acting Antivirals Achieves High-Sustained Virologic Response in Prison PopulationJournal of Correctional Health Care 2019; 25(2): 134 doi: 10.1177/1078345819832875
23
Sabrina Molinaro, Giuliano Resce, Alfredo Alberti, Massimo Andreoni, Pietro P. F. D′Egidio, Claudio Leonardi, Felice A. Nava, Patrizio Pasqualetti, Stefano Villa. Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinicsDrug and Alcohol Review 2019; 38(6): 644 doi: 10.1111/dar.12978
24
Josiah D Rich, Curt G Beckwith, Alexandria Macmadu, Brandon D L Marshall, Lauren Brinkley-Rubinstein, Joseph J Amon, M-J Milloy, Maximilian R F King, Jorge Sanchez, Lukoye Atwoli, Frederick L Altice. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosisThe Lancet 2016; 388(10049): 1103 doi: 10.1016/S0140-6736(16)30379-8
25
Suresh Misra, Douglas T. Dieterich, Behnam Saberi, Tatyana Kushner. Direct-acting antiviral treatment of acute hepatitis C virus infectionsExpert Review of Anti-infective Therapy 2018; 16(8): 599 doi: 10.1080/14787210.2018.1505502
26
Lauren MK Mason, Erika Duffell, Irene K Veldhuijzen, Uarda Petriti, Eveline M Bunge, Lara Tavoschi. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review Eurosurveillance 2019; 24(30) doi: 10.2807/1560-7917.ES.2019.24.30.1800614
27
Zameer Mohamed, Nick Scott, Deyaa Al‐Kurdi, Nowlan Selvapatt, Mark R. Thursz, Maud Lemoine, Ashley S. Brown, Shevanthi Nayagam. Cost‐effectiveness of strategies to improve HCV screening, linkage‐to‐care and treatment in remand prison settings in EnglandLiver International 2020; 40(12): 2950 doi: 10.1111/liv.14628
28
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UKJournal of the International AIDS Society 2016; 19: 21487 doi: 10.7448/IAS.19.8.21487
29
Cheng-Pin Chen, Chien-Yu Cheng, Huachun Zou, Chun-Han Cheng, Shu-Hsing Cheng, Cheng-Kuo Chen, Ching-Hsiang Chen, Ming-Jong Bair. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settingsJournal of Microbiology, Immunology and Infection 2019; 52(4): 556 doi: 10.1016/j.jmii.2018.10.002
30
Jennifer Lorvick, Megan Comfort, Alex H. Kral, Barrot H. Lambdin. Exploring Lifetime Accumulation of Criminal Justice Involvement and Associated Health and Social Outcomes in a Community-Based Sample of Women who Use DrugsJournal of Urban Health 2018; 95(4): 584 doi: 10.1007/s11524-017-0204-8
31
D. Crowley, M. C. Van Hout, C. Murphy, E. Kelly, J. S. Lambert, W. Cullen. Hepatitis C virus screening and treatment in Irish prisons from nurse managers’ perspectives - a qualitative explorationBMC Nursing 2019; 18(1) doi: 10.1186/s12912-019-0347-x
32
Caroline Gahrton, Gabriel Westman, Karin Lindahl, Fredrik Öhrn, Olav Dalgard, Christer Lidman, Lars-Håkan Nilsson, Karouk Said, Ann-Sofi Duberg, Soo Aleman. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm CountyBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4581-3
33
Natasha K. Martin, Lara K. Marquez. Disease Modelling and Public Health, Part BHandbook of Statistics 2017; 37: 93 doi: 10.1016/bs.host.2017.08.007
34
Leonard S Rubenstein, Joseph J Amon, Megan McLemore, Patrick Eba, Kate Dolan, Rick Lines, Chris Beyrer. HIV, prisoners, and human rightsThe Lancet 2016; 388(10050): 1202 doi: 10.1016/S0140-6736(16)30663-8
35
Newaz Hossain, Bharat Puchakayala, Pushpjeet Kanwar, Siddharth Verma, George Abraham, Zhanna Ivanov, Muhammad Obaid Niaz, Smruti R. Mohanty. Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology ClinicsDigestive Diseases and Sciences 2017; 62(11): 3193 doi: 10.1007/s10620-017-4754-0
36
Jana Müller, Daniel Schmidt, Christian Kollan, Marc Lehmann, Viviane Bremer, Ruth Zimmermann. High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in GermanyBMC Public Health 2017; 17(1) doi: 10.1186/s12889-017-4840-4
37
Eric W. Chak, Souvik Sarkar, Christopher Bowlus. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral HepatitisDigestive Diseases and Sciences 2016; 61(10): 2776 doi: 10.1007/s10620-016-4205-3
38
Rob Bielen, Samya R. Stumo, Rachel Halford, Klára Werling, Tatjana Reic, Heino Stöver, Geert Robaeys, Jeffrey V. Lazarus. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countriesHarm Reduction Journal 2018; 15(1) doi: 10.1186/s12954-018-0230-1
39
Jennifer Gratrix, Petra Smyczek, Lindsay Bertholet, M.C. Lee, Diane Pyne, Dan Woods, Keith Courtney, Rabia Ahmed. A cross-sectional evaluation of opt-in testing for sexually transmitted and blood-borne infections in three Canadian provincial correctional facilities: a missed opportunity for public health?International Journal of Prisoner Health 2019; 15(3): 273 doi: 10.1108/IJPH-07-2018-0043
40
Ifeyinwa M. Okafor, Solomon O. Ugwu, Henshaw U. Okoroiwu. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prisonBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01504-8
41
Manuel Mendizabal, Pablo Testa, Mercedes Rojas, Carla S. Colaci, Solana Elías, Paula Nicolini, Soledad Olguín, Carolina Dunn, Claudio Ronchi, Mariano Barreiro, Mercedes Zirpoli, Federico Piñero, Sanjeev Arora, Martín O´Flaherty, Fernando Rubinstein, Marcelo O Silva. Pilot study using the ECHO model to enhance linkage to care for patients with hepatitis C in the custodial settingJournal of Viral Hepatitis 2020; 27(12): 1430 doi: 10.1111/jvh.13374
42
Jacqueline E. Sherbuk, Alexa Tabackman, Kathleen A. McManus, Terry Kemp Knick, Julie Schexnayder, Tabor E. Flickinger, Rebecca Dillingham. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US SouthHarm Reduction Journal 2020; 17(1) doi: 10.1186/s12954-020-00409-9
43
Kristel Kivimets, Anneli Uusküla, Jeffrey V. Lazarus, Kristi Ott. Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3242-2
44
A. Trickey, A. Sood, V. Midha, W. Thompson, C. Vellozzi, S. Shadaker, V. Surlikar, S. Kanchi, P. Vickerman, M. T. May, F. Averhoff. Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, IndiaEpidemiology and Infection 2019; 147 doi: 10.1017/S0950268819001705